Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$24.86 - $35.02 $186,450 - $262,650
-7,500 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$22.3 - $36.02 $211,850 - $342,190
-9,500 Reduced 55.88%
7,500 $262,000
Q4 2020

Feb 08, 2021

BUY
$10.5 - $28.5 $42,000 - $114,000
4,000 Added 30.77%
17,000 $441,000
Q3 2020

Nov 16, 2020

BUY
$3.61 - $9.87 $46,930 - $128,309
13,000 New
13,000 $128,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $405M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Strategic Financial Services, Inc, Portfolio

Follow Strategic Financial Services, Inc, and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Financial Services, Inc,, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Financial Services, Inc, with notifications on news.